Polyclonal Rabbit anti-Human SLC5A11 / SMIT2 Antibody (WB)
Catalog Number: LS-C748223
2 sizes / from $281.00
Antibody: Rabbit Polyclonal
Applications: Immunohistochemistry (general), Western Blot
Reactivity: Human, Mouse, Rat
Format: Liquid
Polyclonal Rabbit anti-Human CD320 Antibody (PE, aa153-182, WB)
Primary AntibodyLSBio Guarantee
| Antibody: | Rabbit Polyclonal |
| Applications: | Enzyme-Linked Immunosorbent Assay, Western Blot |
| Reactivity: | Human |
| Format: | Liquid |
$972.00each
Catalog Number: LS-C253978-200
Catalog Number: LS-C253978
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- CD320 antibody LS-C253978 is a PE-conjugated rabbit polyclonal antibody to human CD320 (aa153-182). Validated for ELISA and WB. Cited in 1 publication.
- Application
- ELISA, WB
- Reactivity
- Hu
- Intended Use
- RUO
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Polyclonal Antibodies
- Alternative Names
- 8D6 antigen | 8D6 | 8D6A | CD320 | CD320 antigen | CD320 molecule | FDC-SM-8D6 | FDC-signaling molecule 8D6 | Transcobalamin receptor | TCBLR
- UniProt Number
- Q9NPF0
- NCBI GenBank
- NM_016579, NP_057663.1
- SwissProt
- Q9NPF0
Target
- Target
- Human CD320
- Antigen Species
- Hu
- Epitope
- This CD320 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 153-182 amino acids from the C-terminal region of human CD320.
- Gene Name
- CD320
Antibody
- Host Species
- Rb
- Clonality
- Polyclonal
- Isotype
- IgG
Immunogen
- Immunogen Type
- SP-Lin
Format
- Conjugate/Label
- PE
- Format
- Liquid
- Formulation
- PBS, pH 7.2, No preservatives added
- Concentration
- 0.45 mg/mL
- Volume
- 200 Microliter
- Preservative
- No
- Purification Method
- AP
Storage & Handling
- Storage Conditions
- May be stored at 4°C before opening. DO NOT FREEZE! Stable at 4°C as an undiluted liquid. Dilute only prior to immediate use. Stable for up to 1 year at 4°C. Protect from light.
- Recommended Storage Buffer
- PBS
A target discovery pipeline identified ILT3 as a target for immunotherapy of multiple myeloma. Francesco Di Meo, Anjushree Iyer, Keith Akama, Rujin Cheng, Christina Yu, Annamaria Cesarano, Noriyoshi Kurihara, Hirofumi Tenshin, Arafat Aljoufi, Silvia Marino, Rajesh K Soni, Julie Roda, James Sissons, Ly P Vu, Monica Guzman, Kun Huang, Tamara Laskowski, Hal E Broxmeyer, David G Roodman, Fabiana Perna. Cell reports. Medicine. 2023 July;4:101110. PubMed: 37467717 PMC: PMC10371025
